Ecosystem
From Discovery to Impact –
Our Innovation Ecosystem Turns Science into Solutions
Evogene’s innovation extends beyond its own walls. Through a global ecosystem of subsidiaries, collaborations, and consortiums, we apply AI-driven computational biology and chemistry to deliver real-world innovation across pharma and agriculture. Each partner in this network leverages Evogene’s scientific expertise to transform discovery into impact, developing sustainable crops, next-generation therapeutics, and novel bio-based products that address real-world needs.
Subsidiaries
-
Casterra Ag Ltd
-
![]()
Casterra, a wholly owned subsidiary of Evogene, is empowering sustainable agriculture through elite castor seed varieties and development of advanced castor farming systems. Casterra leverages advanced genomic capabilities (licensed from Evogene) with its global breeding network to deliver high-yield castor seeds for the bio-based industries. Building on its elite castor seed varieties, Casterra combines agronomic expertise to develop advanced castor farming systems worldwide, tailored to diverse growing conditions, supporting farmers and industries in achieving sustainable production goals while advancing bio-based solutions.
-
biomica Ltd
-
![]()
Established in 2017, Biomica leveraged Evogene’s computational biology platform to discover and develop microbiome-based therapeutics. Targeting oncology, immune-related, and gastrointestinal diseases, the company transformed cutting-edge computational insights into therapies with real-world clinical impact.
In 2025, Biomica initiated a streamlining process, and the company currently focuses on two key goals: completing its oncology program’s clinical trial, expected in early 2026, and the sale of its assets.
-
Lavie Bio Ltd
-
![]()
Established in 2019, Lavie Bio focused on the development of innovative ag-biological solutions for crop protection. In 2025, the majority of Lavie Bio’s activity was acquired by ICL Group Ltd., a leading global specialty minerals company, ensuring the continued growth and global reach of its innovations. Currently, Lavie Bio maintains only its existing collaboration agreement with its existing partner and is expected to distribute funds to its shareholders, with Evogene as the majority holder.
Partners
-
Finally Foods
-
![]()
Harnessing the power of plants to sustainably produce high-value proteins for the food industry, Finally Foods is at the forefront of molecular farming. Leveraging access to Evogene’s GeneRator AI tech engine, the company modifies plants to express functional proteins such as casein, a key dairy component, using the potato plant as a natural bioreactor. Co-founding the company, a seasoned entrepreneur and Evogene’s former VP of R&D collaborated with The Kitchen FoodTech Hub (TKH) by the Strauss Group.
-
Crop4Clima Consortium
-
![]()
Evogene has partnered with the Max Planck Institute in the Crop4Clima Consortium funded by the European Union’s Horizon Europe EIC Pathfinder program, to develop resilient crops, including canola and rapeseed, that thrive under arid conditions, are heat resistant, sequester more carbon, and feature other improved traits for the benefit of farmers and the environment.. Empowering farmers with cost-effective, high-performing crops, with improved and predictable yields, it increases food production without compromising nutritional value, supports growth on marginal lands, and contributes to climate change mitigation and global food security.
Together, We Drive Real-World Innovation
Evogene’s ecosystem represents more than partnerships – it’s a shared mission. By connecting science, technology, and purpose, we accelerate innovation that transforms industries and improves lives worldwide.